U.S. Optic Neuritis Market Industry Insights, Trends, and Forecasts to 2029
The U.S. optic neuritis market is expected to reach
USD 6.11 million by 2029 from USD 4.15 million in 2021, growing at a CAGR of
5.0% in the forecast period of 2029.
Industry Analysis
The growing prevalence of eye disorders in the region
and the rise in the geriatric population has enhanced the demand of the market.
The rising healthcare expenditure for better health services is also attributed
to the growth of the market. The major market players are highly focused on
product launches and approvals during this crucial period. In addition, the
government and regulatory bodies are supporting market players by product
approval due to the surging emergence.
Optic neuritis is characterized as a swelling or
inflammation that occurs in the optic nerve. It is also commonly termed as
optic papillitis and retro tubular neuritis. The optic nerves is a nerve fibres
that has the capability of transmitting visual information from the eye to the
brain. The inflammation usually leads to damage in the optic nerve and
temporary vision loss in only one eye typically. Pediatric optic neuritis and
adult optic neuritis and are two types which is based on the age group of
patients diagnosed with optic neuritis. The common way to diagnose the optic
neuritis is through a physical exam and medical history. The treatment becomes
essential at an early stage due to the lifetime risk of losing human eye vision
in this disorder. The most common symptoms associated with optic neuritis
include pain with eye movement and dyschromatopsia or inability to see colors
correctly. For instance, as per an article in the Journal of Neurology stated
that the annual incidence of optic neuritis in the U.S. is found to be around
5/1,000,000, with an estimated prevalence of 115/1,000,000.
The U.S. Optic
Neuritis Market Scope
The U.S. optic neuritis market is segmented into
treatment, diagnosis, route of administration, end users, and distribution
channel. The growth amongst these segments will help you analyze meager growth
segments in the industries and provide the users with a valuable market
overview and market insights to make strategic decisions to identify core
market applications.
Treatment
·
Corticosteroids
·
IV Immunoglobulin
·
Supplements
·
Others
Diagnosis
·
MRI Scan
·
Lumbar Puncture
·
Ocular Coherence Tomography
·
Blood Test
·
Others
Route of
Administration
·
Parenteral
·
Oral
End User
·
Hospitals
·
Clinics
·
Academic & Research Institutes
·
Others
Distribution
Channel
·
Hospital Pharmacy
·
Retail Pharmacy
·
Others
Get the sample copy of the report here: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=us-optic-neuritis-market
Optic
Neuritis Market Regional Analysis/Insights
The optic neuritis market is analyzed, and market size
insights and trends are provided by country, treatment, diagnosis, route of
administration, end user, and distribution channel, as referenced above.
The U.S. dominates the optic neuritis market in terms
of market share and market revenue and will continue to flourish its dominance
during the forecast period. This is due to implementing awareness programs
regarding the diagnosis and treatments of optic neuritis, and research and
development in the drugs for optic neuritis in the U.S. region further improves
this market growth.
Competitive
Landscape and Optic Neuritis Market Share Analysis
The optic neuritis market competitive landscape
provides details by the competitors. Details include company overview, company
financials, revenue generated, market potential, investment in research and
development, new market initiatives, global presence, production sites and
facilities, production capacities, company strengths and weaknesses, product
launch, product width and breadth, and application dominance. The above data
points provided are only related to the companies' focus on the optic neuritis
market.
Some of the
major players operating in the optic neuritis market are
·
AbbVie Inc.,
·
Bausch & Lomb Incorporated,
·
Boehringer Ingelheim International
GmbH,
·
Novartis AG,
·
Merck & Co., Inc.,
·
Hikma Pharmaceuticals PLC,
·
Fresenius Kabi USA,
·
Teva Pharmaceuticals Industries
Ltd.,
·
GSK plc,
·
Pfizer,
·
Akorn Operating Company LLC,
·
AdvaCare Pharma,
·
Bristol- Myers Squibb Company,
·
Jubilant Cadista Pharmaceuticals
Inc.,
·
Amneal Pharmaceuticals LLC.
·
Viatris Inc.,
·
Novitium Pharma,
·
Among others.
Get Full
Access of reports @ https://www.databridgemarketresearch.com/reports/us-optic-neuritis-market
MAJOR TOC OF THE REPORT
Ø Chapter One: Introduction
Ø Chapter Two: Market Segmentation
Ø Chapter Three: Market Overview
Ø Chapter Four: Executive Summary
Ø Chapter Five: Premium Insights
Ø Chapter Six: U.S. Optic Neuritis Market by
Product & Procedure type
Get TOC
Details: https://www.databridgemarketresearch.com/toc/?dbmr=us-optic-neuritis-market
Browse
Related Reports @
https://www.databridgemarketresearch.com/reports/global-digitally-printed-wallpaper-market
https://www.databridgemarketresearch.com/reports/global-winter-wear-market
https://www.databridgemarketresearch.com/reports/global-edible-films-coatings-market
https://www.databridgemarketresearch.com/reports/global-milk-protein-hydrolysate-market
https://www.databridgemarketresearch.com/reports/global-biometrics-as-a-service-market
https://www.databridgemarketresearch.com/reports/global-iot-monetization-market
About
Us:-
Data Bridge Market Research set forth itself as an unconventional and neoteric
Market research and consulting firm with unparalleled level of resilience and
integrated approaches. We are determined to unearth the best market
opportunities and foster efficient information for your business to thrive in
the market
Contact:-
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
.webp)
Comments
Post a Comment